Should I Buy 03692? 03692 2026 Analysis

Should You Buy HANSOH PHARMA (03692) Today? Analysis, Price Targets, and 2026 Outlook.

No data

Growth

Profitability

Efficiency

0 Analyst Rating

Wall Street analysts forecast 03692 stock price to rise

0 Buy

0 Hold

0 Sell

Current: 36.440

Low

Averages

High

Current: 36.440

Low

Averages

High

CMBI

maintain

AI Analysis

2026-04-02

Reason

CMBI

Price Target

AI Analysis

2026-04-02

maintain

Reason

CMBI issued a Buy rating for Hansoh Pharma due to its strong financial performance in 2025, with significant revenue and profit growth. The company has successfully out-licensed multiple assets and advanced its late-stage drug candidates in clinical trials, indicating a positive outlook for future revenue growth. The broker raised the target price based on strong product sales expectations.

Haitong International

Outperform

maintain

$45.94

2026-04-02

Reason

Haitong International

Price Target

$45.94

2026-04-02

maintain

Outperform

Reason

Haitong International maintains an Outperform rating for HANSOH PHARMA due to the company's strong financial performance, with revenue and net profit showing significant year-on-year growth. The increase in revenue from innovative drugs and collaboration, along with improved operating profit margins, supports the raised revenue and net profit forecasts for 2026 and 2027.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 03692

Unlock Now

03692 Should I Buy

03692 Should I Buy

Should You Buy HANSOH PHARMA (03692) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

Growth

Profitability

Efficiency

People Also Watch